1A03.Y) - Intestinal Infections of Other Specified Escherichia coli

Introduction

Intestinal infections caused by Escherichia coli represent a significant challenge for healthcare professionals worldwide. The ICD-11 code 1A03.Y was created specifically to classify intestinal infections caused by specified strains of E. coli that do not fit into the main pathogenic categories already established, such as enteropathogenic, enterotoxigenic, enteroinvasive, enterohemorrhagic, or enteroaggregative.

Escherichia coli is a gram-negative bacterium that naturally colonizes the human gastrointestinal tract. However, certain strains have developed specific virulence factors that make them pathogenic. While the main diarrheagenic E. coli pathotypes have their own codes in ICD-11, there are other specified variants that cause intestinal disease and require appropriate coding for epidemiological, research, and clinical management purposes.

The clinical importance of this code lies in the ability to track and document infections caused by emerging or less common strains of E. coli that have been identified laboratorially. With advances in molecular diagnostic methods, it has become possible to identify specific strains with distinct genetic and pathogenic characteristics. Correct coding of these infections allows for appropriate epidemiological monitoring, outbreak identification, analysis of antimicrobial resistance patterns, and development of targeted public health strategies. Furthermore, accurate documentation facilitates communication among healthcare professionals and ensures continuity of patient care.

Correct ICD-11 Code

Code: 1A03.Y

Description: Intestinal infections of other specified Escherichia coli

Parent category: 1A03 - Intestinal infections due to Escherichia coli

This code belongs to the chapter on infectious diseases of ICD-11 and was developed to capture cases of intestinal infections caused by strains of E. coli that have been laboratorially identified and specified, but do not correspond to the main pathotypes already coded separately. The ".Y" suffix in ICD-11 nomenclature indicates "other specified," meaning that the causative strain was identified and documented, but does not fit into the main numbered subcategories.

The hierarchical structure of ICD-11 allows this code to be used when there is laboratory confirmation of the specific E. coli strain responsible for the intestinal infection. It is essential that clinical documentation include information about the laboratory identification of the strain, including methods used such as culture, serology, PCR, or genetic sequencing. This specificity ensures that the code is applied correctly and that the epidemiological data generated are reliable for subsequent analyses and public health decision-making.

When to Use This Code

The code 1A03.Y should be used in specific clinical situations where there is laboratory confirmation of intestinal infection by a specified strain of E. coli that does not fit into the main pathotypes. Below, we present detailed practical scenarios:

Scenario 1: Infection by E. coli with Identified Rare Serotype A patient presents with watery diarrhea lasting four days, accompanied by abdominal cramping and low-grade fever. Stool culture identifies E. coli, and subsequent serotyping reveals a specific serotype not classified among the main known pathotypes. The laboratory documents the exact serotype (example: O128:H12), and there is clinical evidence that this strain is causing the gastroenteritis. In this case, with the strain specified and documented, but not belonging to the main groups, code 1A03.Y is appropriate.

Scenario 2: E. coli with Atypical Virulence Profile An outbreak in an institution reveals cases of gastroenteritis associated with an E. coli strain identified by molecular methods. Genetic analysis detects specific virulence genes that do not correspond to the classical patterns of EPEC, ETEC, EIEC, EHEC, or EAEC. The strain is characterized and specified by the reference laboratory, with complete documentation of genetic markers. This scenario justifies the use of code 1A03.Y, as there is clear specification of the causative strain.

Scenario 3: Documented Infection by Uropathogenic E. coli with Intestinal Manifestation Although uropathogenic E. coli strains (UPEC) typically cause urinary tract infections, they can occasionally cause gastrointestinal symptoms when ingested. A patient with a history of improper food handling develops gastroenteritis, and laboratory investigation identifies a specific UPEC strain in stool, with documentation that this is the cause of the intestinal infection. With the strain specified and confirmed as the cause of intestinal disease, code 1A03.Y is appropriate.

Scenario 4: E. coli with Documented Specific Antimicrobial Resistance A hospitalized patient develops diarrhea associated with an E. coli strain identified as a producer of extended-spectrum beta-lactamase (ESBL) or carrying other specific resistance mechanisms. The strain does not fit into the main pathotypes, but was completely characterized by the microbiology laboratory, including resistance profile and genetic characteristics. The detailed specification of the strain justifies the use of code 1A03.Y.

Scenario 5: Infection in the Context of Epidemiological Surveillance During epidemiological investigation of gastroenteritis cases in a community, reference laboratories identify an emerging E. coli strain with specific characteristics that is being tracked for public health purposes. The strain possesses distinct genetic markers and was formally specified by health authorities. Patients infected with this specified strain should be coded with 1A03.Y to allow appropriate tracking and trend analysis.

Scenario 6: E. coli with Uncommon Combination of Virulence Factors A patient presents with gastroenteritis and laboratory analysis reveals E. coli with an atypical combination of virulence factors that does not fit perfectly into any of the classical pathotypes. The strain is specified through advanced molecular methods, with complete documentation of virulence genes present. This specification allows the use of code 1A03.Y to adequately capture this particular variant.

When NOT to Use This Code

It is fundamental to understand the situations in which code 1A03.Y should not be applied to avoid coding errors and ensure accurate epidemiological data.

Do not use when the strain belongs to major pathotypes: If laboratory investigation identifies that the causative E. coli belongs to one of the major pathotypes (enteropathogenic, enterotoxigenic, enteroinvasive, entero-hemorrhagic, or enteroaggregative), use the corresponding specific code (1A03.0, 1A03.1, 1A03.2, etc.), not 1A03.Y.

Do not use when there is no strain specification: Code 1A03.Y requires that the strain be specified. If the laboratory only reports "E. coli present" without further characterization, serotyping, or identification of specific virulence factors, this code is not appropriate. In these cases, it may be necessary to use a more generic code or await more detailed laboratory results.

Do not use for extraintestinal infections: This code is exclusive for intestinal infections. E. coli infections at other anatomical sites (urinary, bloodstream, meningeal, etc.) have their own codes in other ICD-11 categories, even if the strain is specified.

Do not use when there is diagnostic uncertainty: If there is doubt about whether the identified E. coli is truly the causative agent of intestinal symptoms (for example, it may be only colonization), the code should not be applied until there is clinical and laboratory confirmation of the causal relationship.

Do not use for gastroenteritis of unconfirmed etiology: Patients with gastrointestinal symptoms without laboratory confirmation of E. coli as the causative agent should not receive this code, even if there is clinical suspicion. Coding requires laboratory evidence.

Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The first essential step is to confirm that there is an intestinal infection caused by E. coli. Clinically, the patient should present with symptoms compatible with gastroenteritis, which may include diarrhea (watery, mucoid, or bloody), abdominal pain, cramping, nausea, vomiting, fever, and general malaise. The duration and severity of symptoms vary according to the strain involved.

Laboratory confirmation is mandatory for use of this code. Diagnostic instruments include stool culture with isolation of E. coli, molecular tests (PCR) for identification of specific virulence genes, serotyping to determine O and H antigens, and genetic sequencing methods when available. It is necessary to document not only the presence of E. coli, but also characteristics that specify the particular strain involved.

The evaluation should include analysis of clinical history, incubation period, food or environmental exposures, and symptom pattern. Complementary tests such as complete blood count may reveal leukocytosis, and electrolyte evaluation is important in cases of dehydration. Documentation should record all clinical and laboratory findings that support the diagnosis.

Step 2: Verify Specifiers

The fundamental characteristic of code 1A03.Y is that it requires specification of the E. coli strain. Verify that the laboratory report includes information such as specific serotype, genetic profile, identified virulence genes, or other characteristics that differentiate this strain from others.

Assess the severity of the infection, classifying it as mild (minimal symptoms, no dehydration), moderate (significant symptoms with mild to moderate dehydration), or severe (severe dehydration, significant systemic symptoms, need for hospitalization). The duration of symptoms should also be documented, differentiating acute cases (less than 14 days) from prolonged ones.

Specific characteristics of the clinical presentation should be recorded, including type of diarrhea (watery, inflammatory, bloody), presence of fever, signs of dehydration, and associated complications. If applicable, document whether the infection occurred in the context of an outbreak, nosocomial transmission, or special epidemiological situation.

Step 3: Differentiate from Other Codes

1A03.0: Infection by enteropathogenic Escherichia coli (EPEC) The key difference lies in virulence factors. EPEC possesses the eae gene that encodes intimin, causing attaching and effacing lesions. If the identified strain possesses these characteristic EPEC markers, use 1A03.0, not 1A03.Y. EPEC typically affects infants and young children, causing persistent watery diarrhea.

1A03.1: Infection by enterotoxigenic Escherichia coli (ETEC) The main difference is the production of heat-stable (ST) and/or heat-labile (LT) enterotoxins. If laboratory tests confirm production of these toxins or presence of corresponding genes, use 1A03.1. ETEC is frequently associated with traveler's diarrhea and causes profuse watery diarrhea without mucosal invasion.

1A03.2: Infection by enteroinvasive Escherichia coli (EIEC) EIEC possesses the ability to invade intestinal epithelial cells, similar to Shigella, causing bloody diarrhea and dysenteric symptoms. If laboratory characterization demonstrates invasion genes (such as invasion plasmid) or invasive behavior in cell tests, the correct code is 1A03.2, not 1A03.Y.

1A03.3: Infection by entero-hemorrhagic Escherichia coli (EHEC) EHEC produces Shiga toxins (Stx1 and/or Stx2) and frequently causes hemorrhagic colitis, which may progress to hemolytic-uremic syndrome. If there is confirmation of Shiga toxin production or presence of stx genes, use the specific code for EHEC, not 1A03.Y. The O157:H7 serotype is the most well-known, but others also exist.

1A03.4: Infection by enteroaggregative Escherichia coli (EAEC) EAEC adheres to the intestinal mucosa in a characteristic aggregative pattern, forming biofilms. If adhesion tests or presence of specific genes (such as aggR) confirm EAEC, use the appropriate code, not 1A03.Y. EAEC causes persistent diarrhea, especially in children and immunocompromised patients.

Step 4: Required Documentation

Checklist of Mandatory Information:

Detailed description of gastrointestinal symptoms and their temporal evolution
Stool culture results with isolation and identification of E. coli
Strain specification: serotype, genetic profile, virulence genes, or other identifying characteristics
Laboratory methods used for strain characterization
Exclusion of major pathotypes through appropriate tests
Assessment of infection severity and degree of dehydration
Treatments instituted and therapeutic response
Epidemiological context if relevant (outbreak, isolated case, nosocomial transmission)
Patient comorbidities that may influence the clinical presentation
Case evolution and outcome

How to Register Appropriately:

The medical record should begin with detailed clinical presentation, including symptom onset date, characteristics of diarrhea, associated symptoms, and identified risk factors. Document chronologically the diagnostic investigation, including when samples were collected and results obtained.

Laboratory results should be transcribed or attached to the medical record, with special emphasis on the specification of the E. coli strain. If the laboratory provided a detailed report with molecular or serological characterization, this should be an integral part of the documentation.

Record the diagnostic reasoning that led to the conclusion that this specific strain is the causative agent of the intestinal infection, excluding other possibilities. Document why the codes for major pathotypes do not apply and why 1A03.Y is the appropriate code.

Finally, include in the diagnostic summary the phrase "Intestinal infection by Escherichia coli [specify strain/serotype], ICD-11 code: 1A03.Y", ensuring that coders and other professionals have clear access to the information.

Complete Practical Example

Clinical Case

A 42-year-old male patient, previously healthy, seeks medical care with a complaint of diarrhea for three days. He reports that symptoms began approximately 36 hours after attending a social event where he consumed various foods. The diarrhea is described as watery, without visible blood, with a frequency of 6-8 bowel movements per day. He also presents with diffuse abdominal cramping, occasional nausea, and low-grade fever (37.8°C). He denies severe vomiting but reports decreased appetite. There is no history of recent travel or antibiotic use in the past three months.

On physical examination, he appears in good general condition, well-hydrated, with pink and moist mucous membranes. Abdomen slightly distended, increased bowel sounds, diffusely tender on superficial palpation without signs of peritoneal irritation. No palpable masses or visceromegaly. Vital signs stable, except for axillary temperature of 37.6°C.

Laboratory tests were requested including complete blood count (which showed leukocytes of 11,200/mm³ with mild left shift), electrolytes (within normal limits), and stool culture. The patient received guidance on oral hydration, diet, and was prescribed symptomatic treatment, with instructions to return if the condition worsened.

After four days, the microbiology laboratory reports growth of Escherichia coli in the stool culture. The sample was sent to the reference laboratory for further characterization. The patient returns for follow-up consultation, reporting partial improvement of symptoms, with reduction in bowel movement frequency to 3-4 per day.

One week after the initial collection, the reference laboratory issues a detailed report identifying the strain as E. coli serotype O128:H12, with molecular analysis revealing the presence of virulence genes that do not correspond to the classic patterns of EPEC, ETEC, EIEC, EHEC, or EAEC. Specifically, non-characteristic adhesion genes of the main pathotypes were detected, suggesting a distinct pathogenic mechanism. The report confirms that this specific strain has been occasionally associated with gastroenteritis outbreaks in other locations.

Based on this detailed laboratory information, confirming intestinal infection by a specified E. coli strain that does not fit the main pathotypes, the final diagnosis is established.

Coding Step by Step

Criteria Analysis:

Confirmation of intestinal infection: Patient presents clear symptoms of gastroenteritis (watery diarrhea, abdominal cramping, low-grade fever) with duration compatible with acute bacterial infection.
Laboratory identification of E. coli: Positive stool culture confirms presence of E. coli in feces, with significant growth suggesting pathogenic role.
Strain specification: Reference laboratory provided detailed characterization, including serotype (O128:H12) and virulence genetic profile, clearly specifying the strain involved.
Exclusion of main pathotypes: Molecular analysis confirmed that the strain does not possess the characteristic markers of EPEC, ETEC, EIEC, EHEC, or EAEC, excluding the specific codes for these categories.
Established causal relationship: Clinical presentation compatible, appropriate incubation period, absence of other identified pathogens, and prior knowledge that this serotype can cause gastroenteritis establish causal nexus.

Code Selected: 1A03.Y

Complete Justification:

The code 1A03.Y - Intestinal infections of other specified Escherichia coli is the most appropriate for this case for the following reasons:

There is unequivocal laboratory confirmation of intestinal infection by E. coli
The strain was completely specified (serotype O128:H12 with documented genetic profile)
Molecular characterization excluded the main pathotypes that have specific codes
The clinical presentation is consistent with bacterial gastroenteritis
Documentation allows adequate epidemiological tracking of this specific strain

The use of more generic codes would be inappropriate since we have complete strain specification. The codes for main pathotypes (1A03.0 to 1A03.4) were appropriately excluded by laboratory characterization. The code 1A03.Z (unspecified) would be incorrect since there is detailed specification.

Complementary Codes:

Depending on clinical presentation and complications, additional codes may be considered:

If significant dehydration occurred: appropriate code for hydroelectrolytic disorder
If hospitalization was necessary: code for the procedure/admission
To document food exposure as a risk factor, if relevant for epidemiological surveillance

Medical Record Entry:

"Acute gastroenteritis caused by Escherichia coli serotype O128:H12, specified strain not classified among the main diarrheagenic pathotypes. ICD-11: 1A03.Y. Laboratory confirmation by stool culture and molecular characterization at reference laboratory. Favorable evolution with symptomatic treatment and hydration."

Related Codes and Differentiation

Within the Same Category

1A03.0: Infection by enteropathogenic Escherichia coli (EPEC)

When to use 1A03.0: Use this code when laboratory tests confirm that the E. coli strain possesses the virulence factors characteristic of EPEC, especially the eae gene (which encodes intimin) and the capacity to cause attaching and effacing lesions in the intestinal mucosa. Typical EPEC also possesses the EAF plasmid (EPEC adherence factor).

Main difference vs. 1A03.Y: EPEC possesses a well-defined pathogenic mechanism and established specific genetic markers. If laboratory characterization identifies these markers, use 1A03.0. Use 1A03.Y only when the specified strain does not possess the EPEC profile, even if it causes similar symptoms.

1A03.1: Infection by enterotoxigenic Escherichia coli (ETEC)

When to use 1A03.1: This code is appropriate when there is confirmation that E. coli produces heat-stable (ST) and/or heat-labile (LT) enterotoxins. Laboratory tests may detect the toxins directly or identify the genes that encode them (estA/estB for ST, eltAB for LT).

Main difference vs. 1A03.Y: The presence of ST or LT enterotoxins defines ETEC. If toxigenic or molecular tests confirm production of these specific toxins, the correct code is 1A03.1, not 1A03.Y. Use 1A03.Y only when the specified strain does not produce these classic enterotoxins.

1A03.2: Infection by enteroinvasive Escherichia coli (EIEC)

When to use 1A03.2: Apply this code when E. coli demonstrates invasive capacity, penetrating and multiplying within intestinal epithelial cells. EIEC possesses invasion genes located on a virulence plasmid, similar to Shigella. Cell invasion tests or molecular detection of invasion genes confirm EIEC.

Main difference vs. 1A03.Y: Documented invasive capacity and presence of specific invasion genes (such as ipaH) characterize EIEC. If there is evidence of intestinal mucosa invasion by EIEC-specific genetic mechanisms, use 1A03.2. Reserve 1A03.Y for specified strains without this characteristic invasive profile.

1A03.3: Infection by enterohemorrhagic Escherichia coli (EHEC)

When to use 1A03.3: This code should be used when there is confirmation of Shiga toxin production (Stx1 and/or Stx2). EHEC may cause hemorrhagic colitis and hemolytic-uremic syndrome. The O157:H7 serotype is the most well-known, but other serogroups also produce Shiga toxins.

Main difference vs. 1A03.Y: Shiga toxin production is the defining marker of EHEC. Tests that detect the toxins or the stx1/stx2 genes confirm EHEC, requiring code 1A03.3. Use 1A03.Y only when the specified strain does not produce Shiga toxins, regardless of serotype.

1A03.4: Infection by enteroaggregative Escherichia coli (EAEC)

When to use 1A03.4: Use when tests demonstrate characteristic aggregative adhesion pattern in cell cultures (HEp-2 test) or when there is detection of specific genes such as aggR (EAEC master regulator), aatA or aaiC.

Main difference vs. 1A03.Y: The aggregative adhesion pattern and specific regulatory genes define EAEC. If these markers are present, use 1A03.4. Use 1A03.Y for specified strains that do not demonstrate aggregative adhesion nor possess the characteristic EAEC genes.

Differential Diagnoses

Other bacterial gastroenteritides: Infections by Salmonella, Shigella, Campylobacter or Yersinia may present similar symptoms. Differentiation depends on adequate stool culture and specific agent identification. Each pathogen has its own codes in ICD-11.

Viral gastroenteritides: Rotavirus, norovirus and enteric adenovirus cause gastrointestinal symptoms that may be clinically confused. Laboratory confirmation through specific virus tests differentiates these conditions, which have distinct codes.

Inflammatory bowel diseases: Crohn's disease and ulcerative colitis may present with diarrhea and abdominal symptoms. The absence of identified pathogen, chronicity of symptoms and characteristic endoscopic findings differentiate these conditions.

Food poisoning by other agents: Staphylococcus aureus, Bacillus cereus and Clostridium perfringens cause food-related gastroenteritides. The very short incubation period and specific laboratory identification differentiate these conditions.

Differences with ICD-10

In ICD-10, the closest equivalent code would be A04.4 - Other intestinal infections due to Escherichia coli, which encompassed in a less specific manner E. coli infections that did not fit into the main categories.

The main changes in ICD-11 include greater granularity and specificity in classification. While ICD-10 had broader categories, ICD-11 introduced a more detailed hierarchical structure, clearly separating "other specified" (1A03.Y) from "unspecified" (1A03.Z), allowing better epidemiological tracking.

ICD-11 also better reflects advances in molecular diagnostics, recognizing that modern methods allow more precise specification of E. coli strains. The alphanumeric structure of ICD-11 offers greater flexibility for future expansion, as new pathotypes or variants emerge.

The practical impact of these changes is significant for public health surveillance. The ability to distinguish specified strains (1A03.Y) from cases where specification was not performed (1A03.Z) allows more refined analyses regarding diagnostic capacity of health services and identification of emerging strains. For clinical research, the greater specificity facilitates studies on particular strains and their clinical outcomes.

Professionals who used A04.4 in ICD-10 should now evaluate whether there is strain specification to choose between 1A03.Y (specified) or 1A03.Z (unspecified), making coding more precise but also requiring greater attention to laboratory details.

Frequently Asked Questions

1. How is infection by specified E. coli diagnosed?

Diagnosis requires two fundamental steps. First, clinical confirmation of intestinal infection through symptoms such as diarrhea, abdominal pain, and other gastrointestinal signs. Second, and essential for this code, laboratory confirmation through stool culture that isolates E. coli, followed by strain characterization. This characterization may include serotyping (identification of O and H antigens), molecular tests for virulence genes (PCR), genetic sequencing, or specific phenotypic tests. Reference laboratories typically perform detailed characterization when requested by the clinician or when there is epidemiological interest. Complete diagnosis documents not only the presence of E. coli, but specifies which particular strain is causing the infection.

2. Is treatment available in public health systems?

Treatment of intestinal infections by E. coli is generally available in public health systems, although it may vary according to local resources. Most cases require only supportive treatment, which includes oral or intravenous rehydration, electrolyte management, and symptomatic treatment for fever and pain control. These basic resources are widely available. Antibiotics are controversial in many E. coli infections and are generally not recommended, especially in EHEC where they may increase the risk of complications. When indicated, common antibiotics such as fluoroquinolones or azithromycin may be used, but the decision should consider antimicrobial susceptibility testing. Severe cases may require hospitalization for intravenous hydration and monitoring, services generally available in public hospitals.

3. How long does treatment last?

Treatment duration varies according to infection severity and individual response. Mild cases generally resolve spontaneously in 3-7 days with only supportive measures such as adequate hydration. Moderate cases may require 7-10 days of care, including closer monitoring and possible use of symptomatic treatment. Severe cases, especially those requiring hospitalization, may require 10-14 days or more of treatment, depending on clinical progression. When antibiotics are indicated (specific situations determined by the physician), the typical course is 3-5 days. Rehydration should continue until gastrointestinal symptoms completely resolve. Medical follow-up is important to ensure complete resolution and identify possible complications. Patients should be counseled about warning signs that warrant immediate return.

4. Can this code be used in medical certificates?

Yes, code 1A03.Y can and should be used in medical certificates when appropriate, especially in situations requiring absence from work or other activities. Documentation in the certificate should include the descriptive diagnosis (for example, "Gastroenteritis by Escherichia coli serotype [specify]") and may include the ICD-11 code for administrative purposes. It is important that the certificate be clear about the need for absence, especially in professionals who handle food or work in healthcare settings, where the risk of transmission is greater. The period of absence should be based on symptom severity, type of occupation, and transmission risk. Adequate documentation protects both the patient and employers, providing clear medical justification for absence. Some employers or administrative systems may require ICD codes for processing medical leave.

5. What is the difference between this code and 1A03.Z?

The fundamental difference lies in strain specification. Code 1A03.Y is used when the E. coli strain causing intestinal infection has been identified and specified through laboratory methods (serotyping, molecular characterization, etc.), but does not fit the main pathotypes that have their own codes. In contrast, 1A03.Z is used when there is confirmation of intestinal infection by E. coli, but the strain has not been specified - for example, when stool culture only reports "E. coli present" without further characterization. The choice between Y and Z depends on the depth of laboratory investigation performed. In practical terms, 1A03.Y provides more valuable epidemiological information as it allows tracking of specific strains, while 1A03.Z is more generic.

6. Is it necessary to report cases of specified E. coli infection?

The need for reporting varies according to local epidemiological surveillance regulations. Many jurisdictions require reporting of E. coli infections, especially Shiga toxin-producing strains (EHEC) due to the risk of outbreaks and serious complications. Specified strains being tracked for epidemiological surveillance generally require reporting to public health authorities. Isolated cases of non-EHEC strains may not require mandatory reporting, but outbreaks or clusters of cases should always be reported. Healthcare professionals should consult local mandatory reporting guidelines. Even when not mandatory, voluntary reporting of unusual or emerging strains can contribute to surveillance and early identification of public health issues. Reference laboratories typically have established protocols for reporting relevant findings to competent authorities.

7. Do children and elderly require special care?

Yes, young children and the elderly are groups at higher risk for complications from intestinal infections by E. coli and require special attention. Children, especially those under 5 years of age, have a higher risk of severe dehydration due to smaller body volume and higher fluid loss rate. Careful monitoring of dehydration signs (dry mucous membranes, decreased urine output, lethargy) is essential. The elderly also present increased risk due to reduced physiological reserves, frequent comorbidities, and use of medications that may complicate the condition. Both groups may require more frequent hospitalization for intravenous hydration. Medical evaluation should be earlier and the threshold for intervention lower. Clear guidance to caregivers about warning signs, appropriate oral rehydration techniques, and when to seek emergency care are fundamental to prevent serious complications in these vulnerable groups.

8. How to prevent transmission of specified E. coli?

Prevention is based on hygiene and food safety measures. Adequate handwashing with soap and water, especially after using the bathroom and before handling food, is fundamental. Food should be prepared with adequate hygiene, including washing fruits and vegetables, complete cooking of meats (especially ground meat), and avoiding cross-contamination between raw and cooked foods. Potable water from a safe source should be used for consumption and food preparation. Infected patients should avoid preparing food for others until complete resolution of symptoms. Healthcare professionals and food handlers should follow specific protocols for absence from and return to work. In healthcare settings, contact precautions should be implemented. Education about safe hygiene practices and food handling is essential for prevention at the community level.

Conclusion

Code 1A03.Y of ICD-11 represents an important advance in the classification of intestinal infections by Escherichia coli, allowing accurate documentation of cases caused by specified strains that do not fit the main established pathotypes. Appropriate coding requires clear understanding of diagnostic criteria, laboratory confirmation with strain specification, and careful differentiation from other related codes. Healthcare professionals should be familiar with the precise indications of this code, ensuring documentation that supports effective epidemiological surveillance and appropriate clinical care. The transition from ICD-10 to ICD-11 offers an opportunity to improve diagnostic accuracy and contribute to better understanding of E. coli infections at the global level.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-04

Intestinal infections of other specified Escherichia coli

Partager